Recce Pharmaceuticals Ltd
RECEF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $10,449 | $1,944 | $4,415 | $4,009 |
| Short-Term Investments | $237 | $0 | $0 | $0 |
| Receivables | $435 | $71 | $159 | $153 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $208 | $710 | $340 | $199 |
| Total Curr. Assets | $11,386 | $3,008 | $5,136 | $4,844 |
| Property Plant & Equip (Net) | $1,028 | $1,199 | $1,233 | $629 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | -$0 | $0 | $0 | $0 |
| Total NC Assets | $1,028 | $1,199 | $1,233 | $629 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $12,414 | $4,207 | $6,370 | $5,473 |
| Liabilities | – | – | – | – |
| Payables | $2,183 | $3,373 | $3,967 | $1,654 |
| Short-Term Debt | $1,527 | $3,961 | $0 | $122 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,410 | $54 | $10,309 | $2,872 |
| Total Curr. Liab. | $6,129 | $8,398 | $15,070 | $4,648 |
| LT Debt | $8,599 | $0 | $0 | $77 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $319 | $263 | $237 | $138 |
| Total NC Liab. | $9,337 | $796 | $824 | $291 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $643 | $779 | $811 | $77 |
| Total Liabilities | $15,467 | $9,194 | $15,893 | $4,939 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $81,502 | $66,827 | $54,839 | $54,697 |
| Retained Earnings | -$91,504 | -$77,811 | -$70,076 | -$59,876 |
| AOCI | $6,950 | $5,997 | $5,713 | $5,713 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$3,052 | -$4,987 | -$9,524 | $534 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $12,414 | $4,207 | $6,370 | $5,473 |
| Net Debt | -$324 | $2,018 | -$4,415 | -$3,810 |